Stockreport

Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer [Yahoo! Finance]

Aethlon Medical, Inc.  (AEMD) 
NASDAQ:AMEX Investor Relations: ir.aethlonmedical.com
PDF The trial will investigate the device's potential to enhance responses to anti-PD-1 therapies such as Keytruda or Opdivo. Professor Michael Brown and his team enrolle [Read more]